Skip to main
PDEX
PDEX logo

Pro-Dex (PDEX) Stock Forecast & Price Target

Pro-Dex (PDEX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Pro-Dex Inc has demonstrated a significant year-over-year revenue increase of 22%, primarily driven by heightened sales in new medical device products and repairs. The company has also improved its gross margins to 33%, indicating enhanced operational efficiency and profitability. Furthermore, the proactive management strategy of securing new product contracts and investing in private label products has established a robust growth trajectory for the organization.

Bears say

Pro-Dex Inc has revised its FY25 revenue estimates down to $67 million from $68 million, alongside a decrease in EPS expectations from $2.30 to $2.81. The company faces significant risks related to fluctuating demand for technology, competition within the medical device sector, and broader economic conditions that may affect consumer sentiment and industry growth. These factors contribute to a negative outlook on the stock, indicative of potential challenges in achieving financial targets in the foreseeable future.

Pro-Dex (PDEX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Pro-Dex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Pro-Dex (PDEX) Forecast

Analysts have given Pro-Dex (PDEX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Pro-Dex (PDEX) has a Strong Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Pro-Dex (PDEX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.